Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment

Aim It remains unclear how direct‐acting antiviral (DAA) treatments influence hepatocellular carcinoma (HCC) recurrence and survival in comparison with interferon (IFN). Methods In total, 338 patients with chronic hepatitis C virus (HCV) infection and previous HCC treatments who initiated IFN (N = 8...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology research 2020-10, Vol.50 (10), p.1118-1127
Hauptverfasser:	Tahata, Yuki, Sakamori, Ryotaro, Urabe, Ayako, Yamada, Ryoko, Ohkawa, Kazuyoshi, Hiramatsu, Naoki, Hagiwara, Hideki, Oshita, Masahide, Imai, Yasuharu, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Format:	Artikel
Sprache:	eng
Schlagworte:	antiviral therapy Chronic infection Clinical outcomes Gastroenterology & Hepatology Hepatitis Hepatitis C hepatitis C virus, prognosis Hepatocellular carcinoma hepatocellular carcinoma recurrence Interferon Life Sciences & Biomedicine Liver cancer overall survival Patients Science & Technology Survival sustained virologic response
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!